MetaCap

Vir Biotechnology Insider Trades

NASDAQ: VIRHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD

11.70+0.58 (+5.22%)

At close: Oct 9, 4:00 PM ET · Delayed 15 min

Last 12 months

Purchases
0 · $0
Sales
37 · $8.45M
Shares bought / sold
0 / 1.23M
Net activity
Net selling $8.5 million

Vir Biotechnology insider activity

Over the last 12 months, Vir Biotechnology insiders reported 57 transactions on SEC Form 4: 0 open-market purchases and 37 sales. Insiders bought $0 and sold $8.5 million worth of stock, for net insider selling of $8.5 million. The largest seller was SVF Endurance (Cayman) Ltd & SOFTBANK VISION FUND (AIV M1) L.P. & SB INVESTMENT ADVISERS (UK) LTD, with $5.4 million in reported sales.

The most recent filing shows MORE ROBERT J (Director) reporting a transaction in 8,000 shares on Aug 11, 2026. Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put VIR's ownership changes in context.

Summary generated from market data by MetaCap's automated system. Methodology

VIR insider transactions

Vir Biotechnology insider transactions
DateInsiderTypeSharesValueFiling
Aug 11, 2026MORE ROBERT JDirectorother8,000—Form 4
Aug 11, 2026MORE ROBERT JDirectorother8,000—Form 4
Jun 9, 2026Coughlin TimothyDirectorAward8,000—Form 4
Jun 9, 2026Coughlin TimothyDirectorAward8,000—Form 4
Jun 1, 2026Napolitano JanetDirectorSale3,200$30.24KForm 4
Jun 1, 2026Sabatini BrentSVP, Chief Accounting OfficerSale379$3.58KForm 4
May 27, 2026Hatfield Jeffrey S.DirectorAward8,000—Form 4
May 27, 2026Napolitano JanetDirectorAward8,000—Form 4
May 27, 2026BISCHOFBERGER NORBERT WDirectorAward8,000—Form 4
May 27, 2026Farid RamyDirectorAward8,000—Form 4
May 27, 2026MORE ROBERT JDirectorAward8,000—Form 4
May 27, 2026Sigal Charles ElliottDirectorAward8,000—Form 4
May 1, 2026SATO VICKI LDirectorSale22,000$221.03KForm 4
Apr 29, 2026De Backer MariannePresident and CEOother233,532—Form 4
Apr 29, 2026De Backer MariannePresident and CEOother233,532—Form 4
Apr 6, 2026De Backer MariannePresident and CEOSale72,559$664.35KForm 4
Apr 1, 2026SATO VICKI LDirectorSale22,000$199.62KForm 4
Mar 23, 2026Sabatini BrentSVP, Chief Accounting OfficerSale7,711$70.32KForm 4
Mar 20, 2026O'Byrne JasonEVP & Chief Financial Officerother2,500—Form 4
Mar 20, 2026O'Byrne JasonEVP & Chief Financial Officerother2,500—Form 4
Mar 2, 2026SATO VICKI LDirectorSale200$2.00KForm 4
Mar 2, 2026SATO VICKI LDirectorSale21,800$207.19KForm 4
Feb 25, 2026Eisner MarkEVP and Chief Medical OfficerSale1,889$18.55KForm 4
Feb 25, 2026de Verneuil VaninaEVP, General Counsel, Corp SecSale13,700$134.53KForm 4
Feb 24, 2026Eisner MarkEVP and Chief Medical OfficerSale1,616$15.40KForm 4
Feb 24, 2026de Verneuil VaninaEVP, General Counsel, Corp SecSale3,117$29.71KForm 4
Feb 24, 2026De Backer MarianneChief Executive OfficerSale14,762$140.72KForm 4
Feb 24, 2026O'Byrne JasonEVP & Chief Financial OfficerSale1,634$15.58KForm 4
Feb 24, 2026Sabatini BrentSVP, Chief Accounting OfficerSale1,430$13.63KForm 4
Feb 24, 2026SATO VICKI LDirectorSale200$2.05KForm 4
Feb 24, 2026SATO VICKI LDirectorSale42,177$411.31KForm 4
Feb 24, 2026SATO VICKI LDirectorOption exercise42,377$62.93KForm 4
Feb 23, 2026De Backer MarianneChief Executive OfficerSale19,039$141.89KForm 4
Feb 23, 2026Eisner MarkEVP and Chief Medical OfficerSale2,089$15.57KForm 4
Feb 23, 2026de Verneuil VaninaEVP, General Counsel, Corp SecSale4,445$33.13KForm 4
Feb 23, 2026O'Byrne JasonEVP & Chief Financial OfficerSale2,089$15.57KForm 4
Feb 23, 2026Sabatini BrentSVP, Chief Accounting OfficerSale1,829$13.63KForm 4
Feb 22, 2026De Backer MarianneChief Executive OfficerAward285,000—Form 4
Feb 22, 2026Eisner MarkEVP and Chief Medical OfficerAward55,000—Form 4
Feb 22, 2026de Verneuil VaninaEVP, General Counsel, Corp SecAward55,000—Form 4
Feb 22, 2026O'Byrne JasonEVP & Chief Financial OfficerAward55,000—Form 4
Feb 22, 2026Sabatini BrentSVP, Chief Accounting OfficerAward25,000—Form 4
Feb 13, 2026Sabatini BrentSVP, Chief Accounting OfficerSale1,530$11.92KForm 4
Feb 2, 2026SATO VICKI LDirectorSale22,000$169.67KForm 4
Jan 2, 2026SATO VICKI LDirectorSale22,000$130.38KForm 4
Dec 1, 2025SATO VICKI LDirectorSale22,000$132.07KForm 4
Dec 1, 2025SVF Endurance (Cayman) Ltd & SOFTBANK VISION FUND (AIV M1) L.P. & SB INVESTMENT ADVISERS (UK) LTD10% OwnerSale191,854$1.15MForm 4
Nov 28, 2025SVF Endurance (Cayman) Ltd & SOFTBANK VISION FUND (AIV M1) L.P. & SB INVESTMENT ADVISERS (UK) LTD10% OwnerSale61,493$396.01KForm 4
Nov 26, 2025SVF Endurance (Cayman) Ltd & SOFTBANK VISION FUND (AIV M1) L.P. & SB INVESTMENT ADVISERS (UK) LTD10% OwnerSale127,938$817.65KForm 4
Nov 25, 2025SVF Endurance (Cayman) Ltd & SOFTBANK VISION FUND (AIV M1) L.P. & SB INVESTMENT ADVISERS (UK) LTD10% OwnerSale235,971$1.51MForm 4
Nov 24, 2025SVF Endurance (Cayman) Ltd & SOFTBANK VISION FUND (AIV M1) L.P. & SB INVESTMENT ADVISERS (UK) LTD10% OwnerSale227,803$1.40MForm 4
Nov 17, 2025O'Byrne JasonEVP & Chief Financial OfficerSale6,799$37.78KForm 4
Nov 5, 2025de Verneuil VaninaEVP, General Counsel, Corp SecSale2,385$12.31KForm 4
Nov 3, 2025de Verneuil VaninaEVP and General CounselSale1,365$8.00KForm 4
Nov 3, 2025SATO VICKI LDirectorSale22,000$124.05KForm 4
Oct 29, 2025SVF Endurance (Cayman) Ltd & SOFTBANK VISION FUND (AIV M1) L.P. & SB INVESTMENT ADVISERS (UK) LTD10% OwnerSale100$649Form 4
Oct 28, 2025SVF Endurance (Cayman) Ltd & SOFTBANK VISION FUND (AIV M1) L.P. & SB INVESTMENT ADVISERS (UK) LTD10% OwnerSale24,453$159.01KForm 4

Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4

Related